Skip to main content
. 2022 Sep 2;12(9):1223. doi: 10.3390/biom12091223

Table 2.

Patient demographics for low and high differential MYC expression.

Parameter Low
MYC Expression
High
MYC Expression
p-Value
Patients, n 8 13
Age at Diagnosis, median (IQR) 40 (39–44) 47 (46–48) 0.043
Sex 0.37
Male, n (%) 6 (75%) 6 (46%)
Female, n (%) 2 (25%) 7 (54%)
Race 0.13
White, n (%) 6 (75%) 13 (100%)
Black, n (%) 1 (13%) 0 (0%)
Asian, n (%) 1 (13%) 0 (0%)
BMI 0.047
Normal or underweight, n (%) 4 (50%) 1 (8%)
Overweight or Obese, n (%) 4 (50%) 12 (92%)
History of Smoking a, n (%) 4 (50%) 4 (31%) 0.65
Family History b, n (%) 1 (13%) 8 (62%) 0.067
Located at Sigmoid or Rectum, n (%) 3 (38%) 11 (85%) 0.056
Overall Stage 0.53
I, n (%) 1 (13%) 5 (38%)
II, n (%) 2 (25%) 1 (8%)
III, n (%) 4 (50%) 6 (46%)
IV, n (%) 1 (13%) 1 (8%)
Signet/Mucinous component 4 (50%) 0 (0%) 0.012
Lymphovascular Invasion 3 (38%) 4 (31%) 1.00
Peri-neural Invasion 3 (38%) 3 (23%) 0.63

a Positive smoking status includes both current and former smokers at the time of surgery; b Positive family history for colon or rectal cancer in first degree family member. Bold values represent statistically significant differences between high-MYC and low-MYC groups (Fisher’s exact test, p < 0.05).